Donate to Remove ads

Got a credit card? use our Credit Card & Finance Calculators

Thanks to eyeball08,Wondergirly,bofh,johnstevens77,Bhoddhisatva, for Donating to support the site

AstraZeneca Announcement

For discussion of the practicalities of setting up and operating income-portfolios which follow the HYP Group Guidelines. READ Guidelines before posting
Forum rules
Tight HYP discussions only please - OT please discuss in strategies
Post Reply Previous topicNext topic
idpickering
The full Lemon
Posts: 11350
Joined: November 4th, 2016, 5:04 pm
Has thanked: 2475 times
Been thanked: 5794 times

AstraZeneca Announcement

#118991

Postby idpickering » February 19th, 2018, 7:04 am

AstraZeneca's IMFINZI approved for Stage III nsclc

AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the US Food and Drug Administration (FDA) has approved Imfinzi for the treatment of patients with unresectable Stage III non-small cell lung cancer (NSCLC) whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy (CRT).


https://www.investegate.co.uk/astrazene ... 00032013F/
Top
Post Reply Previous topicNext topic

Return to “HYP Practical (See Group Guidelines)”

Who is online

Users browsing this forum: No registered users and 36 guests